The October 2024 issue of The Ocular Surface reveals the direct interventions for the ocular surface manifestations of Mpox. As a reminder, the World Health Organization declared the virus a public health emergency of international concern on Aug. 14. (See https://optometricmanagement.com/news/2024/mpox-know-the-ocular-manifestations/.)

According to the paper, prophylaxis via the JYNNEOS vaccine appears effective in preventing ocular manifestations of Mpox.

Additionally, should ocular Mpox occur, tecovirimat (an anti-viral medication) and steroid eye drops are shown effective in its direct treatment, according to the paper.

For the full paper, visit https://doi.org/10.1016/j.jtos.2024.07.001.